These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7034160)

  • 1. Gastrin secretion before and after gastric bypass surgery for morbid obesity.
    Schrumpf E; Giercksky KE; Nygaard K; Fausa O
    Scand J Gastroenterol; 1981; 16(6):721-5. PubMed ID: 7034160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasting- and meal-stimulated peptide hormone concentrations before and after gastric surgery for morbid obesity.
    Meryn S; Stein D; Straus EW
    Metabolism; 1986 Sep; 35(9):798-802. PubMed ID: 3528741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum gastrin and blood glucose levels in gastroplasty for morbid obesity.
    Miskowiak J; Andersen B; Stadil F; Holst Pedersen J
    Scand J Gastroenterol; 1984 Jul; 19(5):669-72. PubMed ID: 6474088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasting and postprandial serum gastrin levels in obese and slim subjects, and the effects of surgical treatment for obesity on serum gastrin levels.
    Amland PF; Jorde R; Giercksky KE; Kildebo S; Burhol PG
    Acta Chir Scand; 1984; 150(3):223-8. PubMed ID: 6464625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic polypeptide secretion before and after gastric bypass surgery for morbid obesity.
    Schrumpf E; Linnestad P; Nygaard K; Giercksky KE; Fausa O
    Scand J Gastroenterol; 1981; 16(8):1009-14. PubMed ID: 7038840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meal-stimulated gastric acid and gastrin secretion before and after jejuno-ileal shunt operation in obese patients. A preliminary report.
    Hesselfeldt P; Christiansen J; Rehfeld JF; Backer O
    Scand J Gastroenterol; 1979; 14(1):13-6. PubMed ID: 424686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of serum gastrin response to insulin hypoglycemia by selective vagotomy with pyloroplasty in duodenal ulcer patients.
    Emås S; Svensson SO; Lilja B; Kaess H
    Surgery; 1980 Mar; 87(3):294-9. PubMed ID: 6987766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric acid secretion, serum-gastrin levels and psychomotor function under the influence of placebo, insulin-hypoglycemia, and/or bromazepam.
    Stacher G; Bauer P; Brunner H; Grünberger J
    Int J Clin Pharmacol Biopharm; 1976 Jan; 13(1):1-10. PubMed ID: 2560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meal stimulated gastrin and pancreatic polypeptide levels before and after partial gastric transection for morbid obesity.
    Shulkes A; Allen RD; Hardy KJ
    Aust N Z J Med; 1982 Feb; 12(1):27-30. PubMed ID: 6952836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of gastric bypass operation on glucose tolerance in obesity.
    Schrumpf E; Bergan A; Djøseland O; Fausa O; Flaten O; Skagen DW; Tronier B
    Scand J Gastroenterol Suppl; 1985; 107():24-31. PubMed ID: 3885381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of antral pH for gastrin release by insulin hypoglycemia in duodenal ulcer patients.
    Svensson SO; Emås S; Kaess H; Dörner M
    Surgery; 1979 Nov; 86(5):707-13. PubMed ID: 40312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enprostil, a synthetic prostaglandin E2 analogue, inhibits meal-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer.
    Thomas FJ; Koss MA; Hogan DL; Isenberg JI
    Am J Med; 1986 Aug; 81(2A):44-9. PubMed ID: 3092654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma adrenaline and serum gastrin: studies in insulin-induced hypoglycemia and after adrenaline infusions.
    Brandsborg O; Brandsborg M; Christensen NJ
    Gastroenterology; 1975 Mar; 68(3):455-60. PubMed ID: 1112448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on vagal activation of gastric acid secretion in man.
    Stenquist B
    Acta Physiol Scand Suppl; 1979; 465():1-31. PubMed ID: 291298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum gastric inhibitory polypeptide (GIP) in duodenal ulcer disease: relationship to glucose tolerance, insulin, and gastrin release.
    Arnold R; Creutzfeldt W; Ebert R; Becker HD; Börger HW; Schafmayer A
    Scand J Gastroenterol; 1978; 13(1):41-7. PubMed ID: 635445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric acid secretion is abnormally sensitive to endogenous gastrin released after peptone test meals in duodenal ulcer patients.
    Lam SK; Isenberg JI; Grossman MI; Lane WH; Walsh JH
    J Clin Invest; 1980 Feb; 65(2):555-62. PubMed ID: 7356694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum gastrin, insulin and somatostatin levels in normal and obese subjects before and after gastric banding.
    Granström L; Backman L; Uvnäs-Moberg K
    Acta Chir Scand; 1988 Feb; 154(2):117-21. PubMed ID: 2895559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the beta-adrenergic contribution to the gastric acid and gastrin responses to hypoglycaemia in man.
    Christensen KC; Stadil F
    Scand J Gastroenterol Suppl; 1976; 37():81-6. PubMed ID: 1064146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrin determinations in symptomatic patients before and after standard ulcer operations.
    Stremple JF; Elliott DW
    Arch Surg; 1975 Aug; 110(8):875-8. PubMed ID: 1156153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interrelationship between gastric acidity and gastrin concentration in patients with duodenal or gastric ulcer and in healthy subjects.
    Mahachai V; Walker K; Pinchbeck B; Thomson AB
    Clin Ther; 1985; 7(4):424-41. PubMed ID: 4016826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.